Escola Paulista de Medicina
Postgraduate Program in Infectious Diseases

Plasma Metabolomics Biosignature According to HIV Stage of Infection, Pace of Disease Progression, Viremia Level and Immunological Response to Treatment

capa plos 2016 v11

Autores: Scarpelini B, Zanoni M, Sucupira MC, Truong HM, Janini LM, Segurado ID, Diaz RS.


Publicação: PLoS ONE 11(12): e0161920 • DOI: https://doi.org/10.1371/journal.pone.0161920• December 12, 2016


 Abstract: 

Background
We evaluated plasma samples HIV-infected individuals with different phenotypic profile among five HIV-infected elite controllers and five rapid progressors after recent HIV infection and one year later and from 10 individuals subjected to antiretroviral therapy, five of whom were immunological non-responders (INR), before and after one year of antiretroviral treatment compared to 175 samples from HIV-negative patients. A targeted quantitative tandem mass spectrometry metabolomics approach was used in order to determine plasma metabolomics biosignature that may relate to HIV infection, pace of HIV disease progression, and immunological response to treatment.
Results
Twenty-five unique metabolites were identified, including five metabolites that could distinguish rapid progressors and INRs at baseline. Severe deregulation in acylcarnitine and sphingomyelin metabolism compatible with mitochondrial deficiencies was observed. β-oxidation and sphingosine‐1‐phosphate-phosphatase-1 activity were down-regulated, whereas acyl-alkyl-containing phosphatidylcholines and alkylglyceronephosphate synthase levels were elevated in INRs. Evidence that elite controllers harbor an inborn error of metabolism (late-onset multiple acyl-coenzyme A dehydrogenase deficiency [MADD]) was detected.
Conclusions
Blood-based markers from metabolomics show a very high accuracy of discriminating HIV infection between varieties of controls and have the ability to predict rapid disease progression or poor antiretroviral immunological response. These metabolites can be used as biomarkers of HIV natural evolution or treatment response and provide insight into the mechanisms of the disease.

Artigos Relacionados - Artigos Científicos

30 May 2017 10:44

Autores: Nicoletti AG, Marcondes MF, Martins WM, Almeida LG, Nicolás MF, Vasconcelos AT, Oliveira [ ... ]

Artigos Cientificos
30 May 2017 10:44

Autores: Melchior TB, Perosa AH, Camargo CN, Granato C, Bellei N.

Artigos Cientificos
20 Jun 2017 14:24

 

Autor: Nunes ERDM, Zukurov JP, Maricato JT, Sucupira MCA, Diaz RS, Janini LMR

Artigos Cientificos

© 2013 - 2018 Universidade Federal de São Paulo - Unifesp

Hospital São Paulo  •  Rua Napoleão de Barros, 715/737 - 7° andar - Vila Clementino • CEP 04024-002  São Paulo - SP 

telefone: 11 5576-4848 - voip 2557  - infectologia.pg.dipa@unifesp.br
+55 11 5576 4848 Ramal 2557   •  infectologia.pg.dipa@unifesp.br